Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine

Clinical trial NCT00316706 · COMPLETED

Trial details

NCT number: NCT00316706
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cervical Intraepithelial Neoplasia Papillomavirus Infection

Start date: 2005-10-01
Primary completion: 2009-01-01
Enrollment: 1245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.